Point of Care Diagnostics Market Size, Share & Industry Analysis, By Product (Blood Glucose Monitoring, Infectious Disease Testing, Cardiometabolic Disease Testing, Pregnancy & Fertility Testing, Hematology Testing, and Others), By Sample (Blood, Nasal and Oropharyngeal Swabs, Urine, and Others), By End-User (Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, and Home & Self testing), and Regional Forecast, 2025-2032

ATTRIBUTE 

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Growth Rate

CAGR of 6.5% from 2025-2032

Historical Period

2019-2023

Unit

Value (USD Billion)

Segmentation

By Product

• Blood Glucose Monitoring
• Infectious Disease Testing
• Cardiometabolic Disease Testing
• Pregnancy & Fertility Testing
• Hematology Testing
• Others

By Sample

• Blood
• Nasal and Oropharyngeal Swabs
• Urine
• Others

By End-User

• Hospital Bedside
• Physician’s Office Lab
• Urgent Care & Retail Clinics
• Home & Self Testing

By Region

• North America (By Product, Sample, End-User, and Country/Sub-region)
  • U.S. (By Product)
  • Canada (By Product)
• Europe (By Product, Sample, End-User, and Country/Sub-region)
  • U.K. (By Product)
  • Germany (By Product)
  • France (By Product)
  • Italy (By Product)
  • Spain (By Product)
  • Scandinavia (By Product)
  • Rest of Europe (By Product)
• Asia Pacific (By Product, Sample, End-User, and Country/Sub-region)
  • China (By Product)
  • Japan (By Product)
  • India (By Product)
  • Australia (By Product)
  • Southeast Asia (By Product)
  • Rest of Asia Pacific (By Product)
• Latin America (By Product, Sample, End-User, and Country/Sub-region)
  • Brazil (By Product)
  • Mexico (By Product)
  • Rest of Latin America (By Product)
• Middle East & Africa (By Product, Sample, End-User, and Country/Sub-region)
  • GCC (By Product)
  • South Africa (By Product)
  • Rest of the Middle East & Africa (By Product)